Botulinum Toxin Treatment for Depression: A New Paradigm for Psychiatry.

Toxins (Basel) · 2023 · PMC10224294 · PMID 37235370

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

approached significancep < 0.053so close (0.05 < p ≤ 0.1)

A 24-week phase 2 RCT trial with 120 subjects using 30 μ of BoNT/A reported that the BoNT/A group improved significantly, p < 0.05, at 3 and 9 weeks and approached significance at 6 weeks, p < 0.053 [ 6 ].

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.